Related Experiment Video

Updated: Jul 6, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

C3 R102G polymorphism increases risk of age-related macular degeneration

Kylee L Spencer1, Lana M Olson, Brent M Anderson

  • 1Center for Human Genetics Research, Vanderbilt University, Nashville, TN 37232, USA. kylee.spencer@vanderbilt.edu

Human Molecular Genetics
|March 8, 2008
PubMed

Insights

Inflammation is implicated in age-related macular degeneration (AMD). Research shows the C3 R102G gene variant, not L314P, is the primary driver of AMD risk, even with strong linkage disequilibrium.

Area of Science:

  • Ophthalmology
  • Genetics
  • Immunology

Background:

  • Inflammation is a suspected factor in age-related macular degeneration (AMD) pathogenesis.
  • Complement factor H (CFH) and complement factor B (CFB) gene variants link AMD to the alternative complement cascade.
  • C3 is a key component of the alternative complement cascade, with two variants (R102G and L314P) previously associated with increased AMD risk.

Purpose of the Study:

  • To determine if the C3 gene's association with AMD risk is due to the R102G variant, the L314P variant, or both.
  • To clarify the independent contributions of C3 R102G and L314P polymorphisms to AMD pathogenesis.

Main Methods:

  • Genotyping of C3 R102G and L314P polymorphisms in 223 families and 701 cases/286 controls.
  • Analysis of linkage disequilibrium (LD) between the two C3 variants.
  • Conditional analyses to assess the independent effect of each variant on AMD risk.
  • Statistical adjustment for age, smoking, and other AMD-associated genetic variants (CFH, LOC387715, CFB).

Main Results:

  • Both C3 R102G and L314P variants were significantly associated with AMD in family-based and case-control datasets.
  • Strong LD (r(2) = 0.85) was observed between R102G and L314P.
  • Conditional analysis revealed R102G remained significantly associated with AMD in L314P risk allele carriers, but L314P did not show an independent effect in R102G carriers.
  • The R102G variant independently predicted AMD risk (P = 0.015, OR = 1.55) after adjusting for covariates.

Conclusions:

  • The C3 R102G polymorphism, acting alone, provides the strongest model for AMD risk in the studied population.
  • While both variants are linked, R102G appears to be the primary genetic driver of AMD risk associated with this C3 locus.
  • Understanding the specific role of R102G can inform future AMD research and therapeutic strategies targeting the complement cascade.

Related Concept Videos

Genetic Lingo01:11

Genetic Lingo

Overview
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...